Oral News and Research

RSS

Common oral bacterium promotes tumor progression-associated activity in pancreatic cancer cells

Virginia Tech researchers from the Department of Biomedical Engineering and Mechanics and the Department of Biochemistry have discovered a characteristic of a common oral bacterium that relocates to pancreatic cancer tumors that may help guide future therapeutic interventions for treatment.

18 Oct 2022

Study reveals how a cell signaling molecule can help oral cancer cells acquire high motility

The process of metastasis is when cancer cells gain motility and spread to other sites of the body. Because this is one of the main causes of cancer-related deaths, researchers have aimed to develop therapeutic strategies that can block metastasis.

18 Oct 2022

Bioinformatics analysis of monkeypox virus-host cell interactions

A recent study posted to the bioRxiv* preprint server reported the interaction between monkeypox and human cells. Molecular sequences were screened to identify differentially expressed genes (DEGs) and their associated signal pathway, expression regulation, and metabolic pathways.

18 Oct 2022

Scientists use enhanced environmental surveillance for poliovirus type 2 detection in London sewage samples

In a new study, researchers investigated molecular properties of type 2 poliovirus (PV) isolates obtained from sewage samples (SS) to detect PV transmission in communities.

17 Oct 2022

Study reviews hydroxychloroquine and remdesivir antiviral potency against SARS‐CoV‐2

In a new study, researchers outlined the synthesis and the possible mechanism of action (MOA) of two potential severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) repurposing drug candidates.

17 Oct 2022

Owner SARS-CoV-2 RNA load shown to be associated with infection in pet dogs

A new study assessed the potential association of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) load in owners with SARS-CoV-2 infection in their dogs.

17 Oct 2022

Increased TMPRSS2 expression in tongue tissue of females and alcohol drinkers identified as a potential risk factor for SARS-CoV-2 infection

Researchers explored the association between the expressions of the ACE-2 receptor and TMPRSS2 in the tongue tissue and dysgeusia during SARS-CoV-2 infections.

17 Oct 2022

Study uses whole genome sequencing to trace SARS-CoV-2 transmission within Welsh hospital

In a new study, researchers used whole genome sequencing to examine the patients-to-staff, staff-to-patients, and staff-to-staff transmission of SARS-CoV-2 in hospitals in Wales.

17 Oct 2022

After Congress fails to add dental coverage, Medicare weighs limited benefit expansion

Proposed changes in Medicare rules could soon pave the way for a significant expansion in Medicare-covered dental services, while falling short of the comprehensive benefits that many Democratic lawmakers have advocated.

17 Oct 2022

Two cases of acute abdominal pain in patients with COVID-19 in their second week of illness

Researchers described two cases of acute pain in the abdomen of patients with COVID-19.

17 Oct 2022

Advances in nasal delivery of antibiotics

In a recent study published in the Journal of Drug Delivery Science and Technology, researchers reviewed the advances and challenges in the intranasal delivery of antibiotics.

17 Oct 2022

Inhalation therapeutics against COVID-19

A recent study published in the Pulmonary Pharmacology & Therapeutics journal described different inhalation therapeutic agents for treating respiratory viral infections like coronavirus disease 2019 (COVID-19).

17 Oct 2022

Experimental cancer drug shows promise as a treatment for idiopathic pulmonary fibrosis

Researchers have shown that the medication saracatinib shows promise as a treatment for idiopathic pulmonary fibrosis (IPF).

13 Oct 2022

Evaluating SARS-CoV-2 rapid antigen tests using saliva specimen

In a new study, researchers evaluated a rapid antigen test (RAT) that used saliva specimens to detect the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

13 Oct 2022

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC).

12 Oct 2022

What is the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant?

A new review commented on a previous study regarding the real-world effectiveness of oral antivirals against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.

12 Oct 2022

Observational study explores the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant

A new study reported the real-world efficacy of oral antiviral therapies nirmatrelvir plus ritonavir, and molnupiravir on the SARS-CoV-2 Omicron (B.1.1.529) variant, based on an observational study among coronavirus disease 2019 (COVID-19) patients in Hong Kong.

12 Oct 2022

Oral News and Research

Common oral bacterium promotes tumor progression-associated activity in pancreatic cancer cells

Study reveals how a cell signaling molecule can help oral cancer cells acquire high motility

Bioinformatics analysis of monkeypox virus-host cell interactions

Scientists use enhanced environmental surveillance for poliovirus type 2 detection in London sewage samples

Study reviews hydroxychloroquine and remdesivir antiviral potency against SARS‐CoV‐2

Owner SARS-CoV-2 RNA load shown to be associated with infection in pet dogs

Increased TMPRSS2 expression in tongue tissue of females and alcohol drinkers identified as a potential risk factor for SARS-CoV-2 infection

Study uses whole genome sequencing to trace SARS-CoV-2 transmission within Welsh hospital

After Congress fails to add dental coverage, Medicare weighs limited benefit expansion

Two cases of acute abdominal pain in patients with COVID-19 in their second week of illness

Advances in nasal delivery of antibiotics

Inhalation therapeutics against COVID-19

Experimental cancer drug shows promise as a treatment for idiopathic pulmonary fibrosis

Evaluating SARS-CoV-2 rapid antigen tests using saliva specimen

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

What is the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant?

Observational study explores the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant

Molnupiravir and nirmatrelvir-ritonavir treatments are effective in reducing mortality among high-risk COVID-19 patients

Cat allergen immunotherapy works better and more quickly when combined with monoclonal antibody

Are men or women impacted more by adverse reactions to prescription drug treatments?

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News